Research

Madison Memory Study

In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function in subgroups of participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. The group of participants taking Prevagen improved certain aspects of cognitive function according to computer-based testing. The adults were over 40 years old and took one capsule daily (10 mg) for 90 days View The Study
Madison Memory Study
study-page

Safety Study I

Apoaequroin, the unique ingredient in Prevagen, was safely consumed when taken orally using a toxicity study for evaluating dietary supplements. View The Summary
study-page

Safety Study II

Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested. View The Summary
study-page2
study-page

Safety Study III

In a third study conducted on the safety of apoaequroin, apoaequorin was safely consumed when taken orally.

View The Summary

study-page